BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15713956)

  • 21. Epstein-Barr virus, cytokines, and inflammation: a cocktail for the pathogenesis of Hodgkin's lymphoma?
    Khan G
    Exp Hematol; 2006 Apr; 34(4):399-406. PubMed ID: 16569586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammation, microenvironment, and the immune system in cancer progression.
    Keibel A; Singh V; Sharma MC
    Curr Pharm Des; 2009; 15(17):1949-55. PubMed ID: 19519435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NF-kappaB and IKK as therapeutic targets in cancer.
    Kim HJ; Hawke N; Baldwin AS
    Cell Death Differ; 2006 May; 13(5):738-47. PubMed ID: 16485028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracellular JNK, p38 MAPK and NF-kappaB regulate IL-25 induced release of cytokines and chemokines from costimulated T helper lymphocytes.
    Wong CK; Li PW; Lam CW
    Immunol Lett; 2007 Oct; 112(2):82-91. PubMed ID: 17719653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammation and cancer: an ancient link with novel potentials.
    Hussain SP; Harris CC
    Int J Cancer; 2007 Dec; 121(11):2373-80. PubMed ID: 17893866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumour vascularisation: a druggable target.
    Bishop-Bailey D
    Curr Opin Pharmacol; 2009 Apr; 9(2):96-101. PubMed ID: 19056315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis.
    Scaldaferri F; Vetrano S; Sans M; Arena V; Straface G; Stigliano E; Repici A; Sturm A; Malesci A; Panes J; Yla-Herttuala S; Fiocchi C; Danese S
    Gastroenterology; 2009 Feb; 136(2):585-95.e5. PubMed ID: 19013462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of inflammation in cancer and systemic lupus erythematosus.
    Rinaldi I
    Acta Med Indones; 2013 Jul; 45(3):167-9. PubMed ID: 24045384
    [No Abstract]   [Full Text] [Related]  

  • 29. Potential role of NF-kappaB in esophageal adenocarcinoma: as an emerging molecular target.
    Abdel-Latif MM; Kelleher D; Reynolds JV
    J Surg Res; 2009 May; 153(1):172-80. PubMed ID: 18533190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic effects of surgery: quantitative analysis of circulating basic fibroblast growth factor (bFGF), Vascular endothelial growth factor (VEGF) and transforming growth factor beta (TGF-beta) in patients with breast cancer who underwent limited or extended surgery.
    Curigliano G; Petit JY; Bertolini F; Colleoni M; Peruzzotti G; de Braud F; Gandini S; Giraldo A; Martella S; Orlando L; Munzone E; Pietri E; Luini A; Goldhirsch A
    Breast Cancer Res Treat; 2005 Sep; 93(1):35-40. PubMed ID: 16184456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance.
    Saccani A; Schioppa T; Porta C; Biswas SK; Nebuloni M; Vago L; Bottazzi B; Colombo MP; Mantovani A; Sica A
    Cancer Res; 2006 Dec; 66(23):11432-40. PubMed ID: 17145890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate inflammation and its potential impact on prostate cancer: a current review.
    Haverkamp J; Charbonneau B; Ratliff TL
    J Cell Biochem; 2008 Apr; 103(5):1344-53. PubMed ID: 17955503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modifications in the production of cytokines and growth factors in drainage fluids following mesh implantation after incisional hernia repair.
    Di Vita G; Patti R; D'Agostino P; Ferlazzo V; Angileri M; Sieli G; Buscemi S; Caruso G; Arcara M; Cillari E
    Am J Surg; 2006 Jun; 191(6):785-90. PubMed ID: 16720149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of activated nuclear factor-kappaB in the pathogenesis and therapy of squamous cell carcinoma of the head and neck.
    Allen CT; Ricker JL; Chen Z; Van Waes C
    Head Neck; 2007 Oct; 29(10):959-71. PubMed ID: 17405170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of inflammation by tumor cells.
    Arias JI; Aller MA; Arias J
    Cancer; 2005 Jul; 104(2):223-8. PubMed ID: 15937911
    [No Abstract]   [Full Text] [Related]  

  • 36. Renal and vascular hypertension-induced inflammation: role of angiotensin II.
    Ruiz-Ortega M; Esteban V; Rupérez M; Sánchez-López E; Rodríguez-Vita J; Carvajal G; Egido J
    Curr Opin Nephrol Hypertens; 2006 Mar; 15(2):159-66. PubMed ID: 16481883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triamcinolone suppresses retinal vascular pathology via a potent interruption of proinflammatory signal-regulated activation of VEGF during a relative hypoxia.
    Kim YH; Chung IY; Choi MY; Kim YS; Lee JH; Park CH; Kang SS; Roh GS; Choi WS; Yoo JM; Cho GJ
    Neurobiol Dis; 2007 Jun; 26(3):569-76. PubMed ID: 17434742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell signaling in cancer.
    Anagnostopoulos K; Tentes I; Kortsaris AH
    J BUON; 2008; 13(1):17-22. PubMed ID: 18404781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NF-kappaB in solid tumors.
    Pacifico F; Leonardi A
    Biochem Pharmacol; 2006 Oct; 72(9):1142-52. PubMed ID: 16956585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammation, a key event in cancer development.
    Lu H; Ouyang W; Huang C
    Mol Cancer Res; 2006 Apr; 4(4):221-33. PubMed ID: 16603636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.